Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study-Reference-Cited by-同舟云学术

Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

Published:2019-10 Issue:2 Volume:1 Page:e95-e102
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Golder Vera,Kandane-Rathnayake Rangi,Huq Molla,Nim Hieu T,Louthrenoo Worawit,Luo Shue Fen,Wu Yeong-Jian Jan,Lateef Aisha,Sockalingam Sargunan,Navarra Sandra V,Zamora Leonid,Hamijoyo Laniyati,Katsumata Yasuhiro,Harigai Masayoshi,Chan Madelynn,O'Neill Sean,Goldblatt Fiona,Lau Chak Sing,Li Zhan Guo,Hoi Alberta,Nikpour Mandana,Morand Eric F

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference30 articles.

1. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus;Furie;Arthritis Rheum,2011

2. Lupus in crisis: as failures pile up, clinicians call for new tools;Dolgin;Nat Biotechnol,2019

3. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial;Grigor;Lancet,2004

4. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial;Verdecchia;Lancet,2009

5. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force;van Vollenhoven;Ann Rheum Dis,2014

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic glucocorticoid therapy for SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Active implementation of low disease activity state as a treatment endpoint in childhood-onset systemic lupus erythematosus in routine practice is both feasible and associated with better outcomes;Clinical Rheumatology;2024-08-30

3. Disease activity assessment in systemic lupus erythematosus;Frontiers in Lupus;2024-08-21

4. Belimumab in early systemic lupus erythematosus: A propensity score matching analysis;Immunity, Inflammation and Disease;2024-08

5. Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study;The Lancet Rheumatology;2024-08